Moderna surges 33.5% after the company outlines plans to expand its mRNA platform beyond vaccines into oncology, autoimmune diseases and cell therapies.

Messenger RNA (mRNA) vaccines are one of the biggest medical breakthroughs of recent years. It was first introduced during ...

The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.

Shares of Palo Alto Networks, American Airlines Group, and Moderna climbed amid a series of positive catalysts for the ...

The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...

People treated for aggressive melanoma now have a concrete reason to watch a single experimental combination closely. In a ...

Billions of doses later, a global review has found that mRNA vaccines are safe and highly effective. Not only have they ...

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

A sweeping global review led by researchers at the University of British Columbia has found that mRNA vaccines—now ...

A first-of-its-kind flu shot is one step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s mRNA-based vaccine for ...

An experimental mRNA vaccine delayed neuroblastoma growth and sharply reduced tumor size in preclinical models.

By Christy Santhosh and Mariam Sunny June 18 (Reuters) - Advisers to the U.S. Food and Drug Administration on Thursday backed approval of Moderna's flu vaccine for adults aged 50 and older, saying its ...